Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


Hepatitis B serological markers and plasma DNA concentrations.

Price H, Dunn D, Zachary T, Vudriko T, Chirara M, Kityo C, Munderi P, Spyer M, Hakim J, Gilks C, Kaleebu P, Pillay D, Gilson R; DART Virology Group.

AIDS. 2017 May 15;31(8):1109-1117. doi: 10.1097/QAD.0000000000001454.


An effective strategy to diagnose HIV infection: findings from a national audit of HIV partner notification outcomes in sexual health and infectious disease clinics in the UK.

Rayment M, Curtis H, Carne C, McClean H, Bell G, Estcourt C, Roberts J, Wilkins E, Estreich S, Morris G, Phattey J, Sullivan AK; members of the British Society for Sexual Health and HIV National Audit Group, and the British HIV Association Audit and Standards Subcommittee.

Sex Transm Infect. 2017 Mar;93(2):94-99. doi: 10.1136/sextrans-2015-052532. Epub 2016 Aug 5.


Prevalence of hepatitis B and hepatitis C in a UK genitourinary medicine clinic.

Price H, Salimee S, Coelho D.

Int J STD AIDS. 2017 Mar;28(3):238-241. doi: 10.1177/0956462416641528. Epub 2016 Jul 10.


Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights.

Martin NK, Thornton A, Hickman M, Sabin C, Nelson M, Cooke GS, Martin TCS, Delpech V, Ruf M, Price H, Azad Y, Thomson EC, Vickerman P.

Clin Infect Dis. 2016 May 1;62(9):1072-1080. doi: 10.1093/cid/ciw075. Epub 2016 Feb 16.


Systematic review and meta-analysis of L1-VLP-based human papillomavirus vaccine efficacy against anogenital pre-cancer in women with evidence of prior HPV exposure.

Miltz A, Price H, Shahmanesh M, Copas A, Gilson R.

PLoS One. 2014 Mar 3;9(3):e90348. doi: 10.1371/journal.pone.0090348. eCollection 2014. Review.


Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis.

Price H, Dunn D, Pillay D, Bani-Sadr F, de Vries-Sluijs T, Jain MK, Kuzushita N, Mauss S, Núñez M, Nüesch R, Peters M, Reiberger T, Stephan C, Tan L, Gilson R.

PLoS One. 2013 Jul 10;8(7):e68152. doi: 10.1371/journal.pone.0068152. Print 2013. Review.


Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses.

Andrade BB, Hullsiek KH, Boulware DR, Rupert A, French MA, Ruxrungtham K, Montes ML, Price H, Barreiro P, Audsley J, Sher A, Lewin SR, Sereti I; INSIGHT Study Group.

J Infect Dis. 2013 May 1;207(9):1379-88. doi: 10.1093/infdis/jit033. Epub 2013 Jan 18.


Hepatitis B virus infection in HIV-positive individuals in the UK collaborative HIV cohort (UK CHIC) study.

Price H, Bansi L, Sabin CA, Bhagani S, Burroughs A, Chadwick D, Dunn D, Fisher M, Main J, Nelson M, Pillay D, Rodger A, Taylor C, Gilson R; UK Collaborative HIV Cohort Hepatitis Group, Steering Committee.

PLoS One. 2012;7(11):e49314. doi: 10.1371/journal.pone.0049314. Epub 2012 Nov 7.


Positive and negative drug selection pressures on the N348I connection domain mutation: new insights from in vivo data.

Price H, Asboe D, Pozniak A, Gazzard B, Fearnhill E, Pillay D, Dunn D; UK Collaborative Group on HIV Drug Resistance; UK Collaborative HIV Cohort Study.

Antivir Ther. 2010;15(2):203-11. doi: 10.3851/IMP1511.


The impact of the 0-0 cell on measures of amino acid covariation.

Dunn D, von Wyl V, Price H, Asboe D.

AIDS. 2010 Jan 2;24(1):159-60. doi: 10.1097/QAD.0b013e32833156ab. No abstract available.


Do the mutations M046I and I047A confer resistance to kaletra?

Price H, Jones R, Stevanovic M, Nelson M, Bower M, Mandalia S, Gazzard B.

AIDS. 2006 Apr 4;20(6):950-1. No abstract available.


Biochemical markers for post-operative fatigue after major surgery.

McGuire J, Ross GL, Price H, Mortensen N, Evans J, Castell LM.

Brain Res Bull. 2003 Apr 15;60(1-2):125-30.


Supplemental Content

Loading ...
Support Center